Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 16/20 | 0.38 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.34 |
| ▸ | MYC | P01106 | 1/20 | 0.34 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.34 |
| ▸ | MAP2K3 | P46734 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19507302 | 0.93 | NLRP3 (0.42) | NLRP3SOAT2MYCSOAT1MAP2K3 | |
| SCHEMBL19507298 | 0.83 | NLRP3 (0.51) | NLRP3SOAT2MYCSOAT1MAP2K3 | |
| SCHEMBL19507301 | 0.83 | NLRP3 (0.46) | NLRP3SOAT2MYCSOAT1MAP2K3 | |
| SCHEMBL19507899 | 0.82 | NLRP3 (0.52) | NLRP3SOAT2MYCSOAT1MAP2K3 | |
| SCHEMBL19507901 | 0.80 | NLRP3 (0.43) | NLRP3SOAT2MYCSOAT1MAP2K3 | |
| SCHEMBL19507107 | 0.77 | NLRP3 (0.55) | NLRP3SOAT2MYCSOAT1MAP2K3 | |
| SCHEMBL20932982 | 0.77 | NLRP3 (0.55) | NLRP3SOAT2MYCSOAT1MAP2K3 | |
| SCHEMBL19507893 | 0.76 | NLRP3 (0.51) | NLRP3SOAT2MYCSOAT1MAP2K3 | |
| SCHEMBL30145289 | 0.76 | NLRP3 (0.54) | NLRP3SOAT2MYCSOAT1MAP2K3 | |
| SCHEMBL19507897 | 0.76 | NLRP3 (0.54) | NLRP3SOAT2MYCSOAT1MAP2K3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017184604-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | IFM THERAPEUTICS, INC (US) | 2017-10-26 | — | — | WO | disclosed |